New medical treatment for the neuropsychiatric symptoms of Alzheimer’s disease
As the population gets older, disturbances caused by Alzheimer’s disease create a growing problem. Orion Pharma has made a drug discovery, now under clinical development, which affects the symptoms of Alzheimer’s disease by means of completely new mechanisms. The further development of the drug is done in cooperation with the pharma company Janssen Pharmaceuticals. Preliminary clinical trials have already shown the effect of the drug target on patients with Alzheimer’s disease. To our knowledge, Orion Pharma is the only company developing a drug based on this mode of action.